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Abstract
Low spatial frequency (SF) processing has been shown to be impaired in people
with schizophrenia, but it is not clear how this varies with clinical state or illness
chronicity. We compared schizophrenia patients (SCZ, n534), first episode
psychosis patients (FEP, n522), and healthy controls (CON, n535) on a gender/
facial discrimination task. Images were either unaltered (broadband spatial
frequency, BSF), or had high or low SF information removed (LSF and HSF
conditions, respectively). The task was performed at hospital admission and
discharge for patients, and at corresponding time points for controls. Groups were
matched on visual acuity. At admission, compared to their BSF performance, each
group was significantly worse with low SF stimuli, and most impaired with high SF
stimuli. The level of impairment at each SF did not depend on group. At discharge,
the SCZ group performed more poorly in the LSF condition than the other groups,
and showed the greatest degree of performance decline collapsed over HSF and
LSF conditions, although the latter finding was not significant when controlling for
visual acuity. Performance did not change significantly over time for any group. HSF
processing was strongly related to visual acuity at both time points for all groups.
We conclude the following: 1) SF processing abilities in schizophrenia are relatively
stable across clinical state; 2) face processing abnormalities in SCZ are not
secondary to problems processing specific SFs, but are due to other known
difficulties constructing visual representations from degraded information; and 3)
the relationship between HSF processing and visual acuity, along with known SCZ-
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and medication-related acuity reductions, and the elimination of a SCZ-related
impairment after controlling for visual acuity in this study, all raise the possibility that
some prior findings of impaired perception in SCZ may be secondary to acuity
reductions.
Introduction
The presence of visual processing impairments is now well established in
schizophrenia [1–5], and evidence is increasing for their etiologic [6, 7] and
functional [8, 9] significance. A relatively unaddressed question in this literature,
however, is whether (or which of) these impairments are state-linked, reflecting
processes involved in the acute phase of illness, versus having trait status, possibly
reflecting the diathesis for the disorder. Emerging evidence suggests that visual
processing that is strongly driven by top-down modulation involving prior
experience is state-linked [10–13] whereas processing that reflects primarily
bottom-up influences is stable across clinical state [14]. However, there is little to
no data on this issue for most visual processes that have been studied in
schizophrenia.
One well-studied visual function in schizophrenia is spatial frequency
processing. Much evidence now suggests that schizophrenia patients show a
differential impairment in processing low spatial frequencies (LSFs) [15, 16], but
this is not a universal finding. For example, some studies suggest a bias towards
LSF processing when viewing faces, suggesting a problem integrating information
across spatial frequencies [17, 18]. This conclusion is consistent with research on
faulty integration of magnocellular and parvocellular pathway information in
schizophrenia [19]. Others studies suggest that LSF information is detected
normally but processed excessively, leading to disruptions in higher level visual
tasks [20]. Still others indicate that the processing of all spatial frequencies (SFs) is
impaired in schizophrenia and that this reflects attentional dysfunction rather
than a primary visual impairment [21]. Some studies indicating reduced LSF
processing have also found increased high spatial frequency (HSF) processing
[22–24], while still others have demonstrated a specific impairment in processing
HSFs [25]. It is not clear what the explanation is for this range of findings,
although it is likely to reflect several factors. One is differences in the tasks used. A
second is differences between studies in whether stimuli were presented at
threshold or were suprathreshold. In general, LSF processing, and its
corresponding putative neurobiological basis in magnocellular pathway activity, is
most accurately measured at low contrast, threshold levels [26, 27]. A third factor
is differences in visual acuity between groups. Schizophrenia patients are known
to have poorer acuity than the general population [28, 29], and this would be
expected to reduce fine detail (i.e., HSF) processing and create a bias towards LSF
processing. Alternatively, it could create the appearance of difficulties at all spatial
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frequencies whereas, if acuity were optimized via an adequate prescription for
corrective lenses, only an LSF impairment would remain (presumably reflecting
the true nature of visual system pathophysiology). A fourth factor is the clinical
characteristics of patients studied - schizophrenia is known to be a heterogeneous
condition and factors such as level of premorbid functioning, and degrees of
positive, negative, and disorganized symptoms have each been shown to be
associated with performance on different perceptual tasks in patient samples in
past studies [2, 10, 30–34]. In addition, first episode psychosis has been
characterized by heightened LSF processing [23, 35, 36], which may be an aspect
of a general hyperactivity in brain networks [37] that is no longer present in more
chronically ill patients, who have often shown reduced LSF processing [38, 39].
Furthermore, as noted above, it is unclear whether these SF impairments are
state-related. O’Donnell found impaired discrimination of sinusoidal luminance
gratings at low, but not high, SFs in medicated schizophrenia patients [40], and
Kiss et al. [14] replicated this finding in a sample of remitted, unmedicated, high
functioning outpatients with schizophrenia who also demonstrated normal IQs
and intact attentional functioning. These studies suggest that the LSF processing
impairment is a trait-like visual processing deficit in schizophrenia. To our
knowledge, however, there has been only a single study examining SF processing
longitudinally in the same patients as they move from the acute to the
stabilization phase of illness (following the clinical state distinctions of Lehman et
al [41]). Kelemen et al. [23] studied medication nai¨ve first episode schizophrenia
patients at baseline (whether or not the person was in the hospital at baseline
testing was not reported) and after 8 weeks of treatment with an antipsychotic
medication. Excessive LSF processing was noted at baseline, but not at follow-up,
suggesting that medication normalizes hyperactive LSF processing and magno-
cellular pathway activity, at least in first episode patients. In contrast to Kelemen
et al., in the present study, all first episode patients were hospitalized and on
medication at the time of the initial assessment, and later-episode patients were
included in the study.
Specifically, we examined the effects of SF manipulations on emotionally
neutral face processing in the context of performing a gender-discrimination task
that had been used in a prior fMRI study of SF removal effects on face processing
in schizophrenia [24]. We chose a gender-discrimination task for several reasons,
including: (1) gender discrimination is a relatively simple task and is therefore
unlikely to introduce confounds from a generalized deficit, reduced motivation
and/or anxiety due to failure experiences [42]; (2) ERP studies in humans and
monkeys demonstrate that gender discrimination tends to occur separately from
and faster than the structural encoding responsible for detection of identity or
expression [43–45]; and (3) gender processing does not seem to interfere with
detection of either facial features or global processing of faces [45]. We
manipulated the SF composition of faces in two ways. First, to increase the
salience of global form (LSF condition), we removed HSF. Second, to increase the
salience of local contour information (HSF condition), we removed LSF. The
rationale for these manipulations is supported by studies indicating that when
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forced to rely on either high or low SF data alone for face identification, healthy
adults and children above 8 months of age tend to rely on low SF information,
which may represent a tendency to initially encode the global structure of the face
to determine identity [42, 46] [47, 48]. Recent ERP data also confirm the
association between global and LSF processing, and local and HSF processing
[49].
A second purpose of the study was to compare people with an established
diagnosis of schizophrenia to people experiencing a first episode of psychosis
(many of whom will likely be diagnosed later as having schizophrenia [50, 51]) to
determine the degree to which task performance is affected by illness progression.
This is an important question because while some aspects of perceptual
impairment can be detected in first-episode patients [35, 52, 53], others emerge
over time [12, 54, 55] and may thus reflect progressive changes in brain structure
or function (e.g., related to loss of gray and white matter in the occipital cortex
[56]). There is also, as noted above, evidence suggesting that extent of LSF
processing may shift from being excessive to being reduced from first to later
illness episodes, although, to our knowledge, there are no published data directly
comparing first- and later-episode patients on the same task of SF processing. In
addition, whether first- and later-episode patients would demonstrate similar
degrees of change in performance during recovery from an acute psychotic
episode has not been reported.
Method
Subjects
One hundred twenty subjects (FEP529; SCZ548; CON543) completed data
collection at the initial (admission) testing (i.e., Time 1). Of these, ninety-four
subjects completed the gender discrimination task at both time points (23 FEP, 36
SCZ, 35 CON). Attrition was due to lack of interest in completing the second
session, and, for some patients, sudden hospital discharge or transfer to another
hospital. In addition, data from 1 FEP and 2 SCZ subjects were excluded for
performing below chance (see below, Data analysis strategy), at one or both time
points, in the BSF (easiest) condition, leaving final sample sizes of 22 FEP, 34 SCZ,
and 35 CON (see Table 1 for gender and demographic distributions within
groups). Patients were tested as close as possible to their hospital admission and
discharge dates. Controls were tested at corresponding time points. All patient
diagnoses were confirmed with the Structured Clinical Interview for DSM-IV
Diagnosis (SCID), patient version [57], and symptoms were assessed with the
Positive and Negative Syndrome Scale [58], which was scored using a 5-factor
model (positive, negative, cognitive, excitement, depression) [59, 60].
Additionally, a separate factor was derived for disorganized symptoms [61] that
consisted of the original PANSS items conceptual disorganization and poor
attention, and an added item for inappropriate affect [61]. The absence of
diagnosable clinical conditions in the CON group was established using the SCID,
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non-patient version [62]. Socioeconomic status (SES) was determined for all
subjects, and their parents (via subject report), using an updated version of the
Nakao-Treas scale [63].
To be included in the study, patients had to be between the ages of 18–60, and
diagnosed with either schizophrenia, or a first episode of a psychiatric disorder
with psychotic symptoms. Exclusion criteria included: (1) any history of TBI or
head injury with loss of consciousness greater than 10 min; (2) history of a
neurological or developmental disorder; (3) current mood disorder; (4) current
substance abuse or dependence disorder (within past 6 months) or positive urine
toxicology screen on any day of testing; (5) estimated premorbid (Wechsler)
IQ,70, as determined by the Shipley Institute of Living Scale [64] or evidence of
intellectual disability as indicated in the electronic medical record; or (6) ECT
within the past 8 weeks. All patients were receiving antipsychotic medication.
Exclusion criteria for the CON group included those listed for patients, as well as:
(1) any lifetime DSM-IV Axis-I disorder (as assessed by SCID) with the exception
of past substance use disorders; (2) psychotropic medication use in the last 6
months; and (3) first-degree relative(s) with a diagnosis of schizophrenia,
schizoaffective disorder, or bipolar disorder (based on subject self report). All
subjects had normal or corrected-to-normal visual acuity as assessed via a Snellen
chart. For subjects who initially had poor acuity (poorer than 20/40 Snellen
values), corrective lenses (Vision Correction Lenses, Psychology Software Tools,
Inc., Pittsburgh, PA, 15215) were worn to optimize acuity to the extent possible.
The study was approved by the IRB at Rutgers-Robert Wood Johnson Medical
Center. All investigators completed on-line training in responsible and ethical
conduct of research at their respective institutions. All subjects provided written
informed consent, and were deemed to have the capacity to provide consent. The
latter was ensured by: 1) requiring referrals to the study to be made by inpatient
Table 1. Demographic data.
FEP (n522) SCZ (n534) CON (n535)
Age 26.32(9.82) 40.09(10.90) 43.74(11.97)
Gender 11 M/11 F 22 M/12 F 16 M/19 F
Race 10 W/5 AA/7 A 15 W/13 AA/6 A 15 W/13 AA/7 A
Ethnicity 19 NH/3 H 28 NH/5H 30 NH/5 H
Education 13.09(2.89) 13.06(1.65) 14.06(2.31)
SES 47.02(20.80) 36.36(14.62) 53.78(17.97)
Maternal Education 13.33(4.29) 12.65(4.42) 12.49(4.56)
Paternal Education 13.80(3.82) 13.04(4.20) 12.09(4.84)
Maternal SES 53.63(22.28) 47.18(20.95) 53.15(21.03)
Paternal SES 57.03(21.18) 52.48(20.91) 52.02(24.29)
Acuity – Left eye .08(.10) .13(.13) .11(.11)
Acuity – Right eye .12(.15) .14(.13) .13(.13)
Acuity – Both eyes .06(.08) .11(.14) .09(.12)
doi:10.1371/journal.pone.0114642.t001
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staff members, and to be limited only to patients they believed had the capacity to
understand the study and the voluntary nature of participation; 2) having trained
research assistants review all sections of the consent form with the patient prior to
the latter signing it; and 3) after the review of the consent form, asking the patient
a series of three IRB-approved questions (listed at the end of the consent form) to
ensure that they understood the purpose of the study, the tasks they would be
completing, and the voluntary nature of participation, including the lack of any
penalties for withdrawal at any time. Patient responses were compared to IRB-
approved response alternatives that were considered to meet criteria for
comprehension of the study and its procedures. Only patients who completed all
three questions correctly and who then provided written informed consent were
allowed to participate. Patient responses were recorded on the consent form and
are available for IRB audit.
Stimuli and procedure
Stimuli were black-and-white photographs of emotion-neutral faces taken from
the Nim Stim facial database [65]. Background information was removed
although the hair remained. There was a good distribution of different genders
and ethnicities although there were not enough images to completely balance race
and gender for all conditions. Represented groups include African-American
Males, White Males, Asian Males, African-American Females, White Females and
Asian Females. The stimulus conditions were: 1) normal or broad spatial
frequency (BSF) faces (i.e., unmanipulated images); 2) HSF faces, which
contained images with low frequency signals removed; and 3) LSF faces, which
contained images with high frequency signals removed. The spatial-frequency
content in the original images was altered using procedures similar to those of Bar
and colleagues for fMRI studies of HSF and LSF processing [66]. Specifically,
using the Image Processing Toolkit and PhotoshopCS (Adobe, USA), images were
transformed into Fourier space and thresholded with a bilevel threshold tool. LSF
images were thresholded to 1.790 cycles/degree and HSF images were thresholded
to 7.517 cycles/degree. Images were then smoothed using a 5-pixel-radius
Gaussian filter and were converted back into image space. An example stimulus
from each condition is shown in Fig. 1.
Across 108 trials [36 in each condition: BSF, HSF, LSF], after presentation of a
facial image, subjects had to press one key if they perceived the figure to be a male,
and another key if they perceived the figure to be female. Face stimuli appeared
centrally on the screen for 325 milliseconds, and the trial continued until the
subject responded (to ensure a response on each trial). Following a participant’s
response, there was a 1-second interval before the next trial began. The 108 stimuli
were broken up into 2 blocks of 54 stimuli. Stimuli from each condition were
pseudo-randomly intermixed (in equal numbers) in each block, with randomi-
zation varying across subjects. There was a 30-second break between blocks. Prior
to data collection, there were 12 practice trials, which were composed of 4 stimuli
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from each condition, to ensure that subjects understood the task. The entire face
perception task took approximately 6 minutes to complete.
Stimuli were presented on a Samsung 2243BWX LCD monitor with viewable
dimensions of 47.5 by 29.8 cm. The viewing distance was 24 inches (60.9 cm), and
therefore, the viewable screen subtended 37.95˚626.07˚of visual angle. The screen
resolution was 168061050 pixels. Each image was 10.5 cm high 67 cm wide,
thus subtending 9.78˚ by 5.56˚ of visual angle. Images presented in the
experimental task were scaled to 82% of their original size, and so the spatial
frequency of the LSF images was 2.17 cycles/degree, and of the HSF images was
9.10 cycles/degree.
Spyder 3 Elite software was used to calibrate the monitors at the start of the
study and then monthly afterwards. Monitor parameters were a gamma value of
2.2, color temperature (white point) of 6500K, and luminance of 120 cd/m2.
Data analysis strategy
Data were included for subjects who scored at least 61.11% correct (or 22 out of
36 correct) in the BSF condition, at both time points. Under a binomial
distribution, with 36 trials, 23 or more trials would be correct by chance less than
5% of the time. As noted above, this led to exclusion of data from 1 FEP and 2
SCZ subjects. Note, however, that the findings using the entire sample were
essentially identical to what was observed with the 3 excluded subjects (see S1
Results). In S1 Results, we also present analyses using: 1) all subjects who scored
above chance at Time 1 (i.e., admission) regardless of whether they were present
at Time 2 (i.e., discharge), or (if present) their performance level at Time 2; 2)
only subjects who scored above 90% accuracy in the BSF condition at Time 1; this
ensured that the data reflected only subjects who could perform the task with a
high degree of accuracy, thereby reducing confounds related to keypress errors
and attention lapses [FEP mean596.50(SD5.03), SCZ596.11(.03)5,
CON597.81(.03)]; and 3) patients who were present versus those who were not
present at Time 2, on Time 1 variables to address the issue of drop-out bias.
To analyze the data on visual acuity, Snellen fractions (e.g., 20/40) were
converted to logarithm of the minimum angle of resolution (LogMAR) units. The
Fig. 1. Examples of BSF (left), HSF (center), & LSF (right) stimuli from gender discrimination task.
doi:10.1371/journal.pone.0114642.g001
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latter provide more accurate estimates of vision when using parametric statistics
[67].
Antipsychotic medication dosages were converted to chlorpromazine (CPZ)
equivalent units, following established procedures [68]. These values were then
correlated with task performance indices to determine if cross-sectional
relationships existed, and if medication change over time was related to any
performance change over time. A second set of similar analyses were done using
benzodiazepine dosages, which were also converted to standardized units,
representing diazepam dosage [69].
Initial analyses compared the three groups on the BSF condition, as poorer
performance in the patient groups (compared to the CON group) in this
condition could be indicative of a generalized performance impairment. Since this
difference was significant (see below), to remove its impact from our analyses, the
critical indices for this study were calculated such that they represented the
contrasts in performance between BSF and the LSF, and HSF, conditions (i.e., the
relative performance decrement due to spatial frequency manipulation, in each of
the 2 degraded conditions). Groups were compared on these 2 variables at each
time point, and these indices were correlated with symptom factor scores in the
patient groups to determine if performance was related to symptoms. We also
calculated a differential sensitivity index which represented [(BSF-LSF) – (BSF-
HSF)], to identify the relative effects of removing one SF type over the other. We
then compared this between groups. On this differential sensitivity index, a more
negative score would indicate a greater performance decrement from BSF in the
HSF condition compared to the decrement from BSF in the LSF condition. A
score of 0 would indicate equal performance decrement from BSF in both
degraded conditions, and a positive score would indicate greater performance
decrement from BSF in the LSF condition compared to the decrement from BSF
in the HSF condition. Finally, we calculated an overall degradation index (i.e.,
decline in performance due to any type of stimulus degradation) by summing the
degree of performance decrement in the LSF and HSF conditions, and then
comparing groups on this variable. Data on both accuracy and reaction time (RT)
(for correct responses) are reported.
Results
Demographic and clinical data (see Table 1)
Demographic data
The groups differed significantly in age: F(2, 90)517.50, p,.001. Post-hoc Scheffe´
tests indicated that, as expected, the FEP group was younger than both the SCZ
and CON groups (ps ,.001), who did not differ from each other (p5.40). The
groups did not differ in terms of education attainment (F(2,90)52.06, p5.13), or
composition in terms of gender [X2(2)52.67, p5.26], race [X2(4)52.44, p5.66],
or ethnicity (Hispanic vs. non-Hispanic) [X2(2)5.03, p5.99]. There was a
significant group difference on SES [F(2,56)56.55, p5.003], with the SCZ group
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having lower attainment than the CON group (p5.003), but not the FEP group
(p5.29). The FEP and CON groups did not differ on SES (p5.63). There were no
group differences in terms of maternal [F(2,86)50.25, p5.78] or paternal
[F(2,81)51.00, p5.37] education, or maternal [F(2,60)50.65, p5.53] or paternal
[F(2,66)50.33, p,5.72] SES status.
Time between testing sessions
The average duration between testing time points was 15.41 days (SD56.43;
range56–35). There was a significant between-groups difference in the number of
days between testing sessions: F(2,90)54.92, p5.009. Post-hoc Scheffe´ tests
indicated that the number of days between testings for the SCZ group
(mean512.82, SD55.01) was significantly less than for the CON group (17.31,
5.54) (p501). The SCZ and FEP (16.36, 8.38) groups did not differ (p5.12), nor
did the FEP and CON groups (p5.85). Because the homogeneity of variance
assumption was violated for the ANOVA, the groups were also compared using
Kruskal-Wallis and median tests, which were also significant (ps5.001 and.03,
respectively).
Visual acuity
The groups did not differ in acuity: left eye F(2,83)50.96, p5.34; right eye
F(2,83)50.06, p5.94), binocular (F(2,83)50.94, p5.39).
Symptoms
At admission, the FEP and SCZ groups did not differ in their level of symptoms:
positive t(52)52.33, p5.74; negative t(52)521.25, p5.21; cognitive
t(52)52.82, p5.42; excitement t(52)5.81, p5.42; depression t(52)52.95,
p5.35; disorganization t(52)521.03, p5.31. At discharge, the groups were also
similar: positive t(52)521.00, p5.32; negative t(52)52.89, p5..38; cognitive
t(52)521.03, p5.31; excitement t(52)52.12, p5.91; depression t(52)52.40,
p5.69; disorganization t(50.96)521.63, p5.11.
Analyses of change over time from admission to discharge, for both patient
groups combined, indicated that symptoms were significantly reduced at Time 2
compared with Time 1, confirming clinical improvement between time points:
positive t(51)56.15, p,.001; negative t(51)53.57, p5.001; cognitive t(51)53.67,
p5.001; excitement t(51)54.03, p,.001; depression t(51)54.75, p,.001;
disorganization t(51)53.86, p,.001. When analyzed for each patient group
separately, this effect was significant [using MANOVAs with the first 5
(orthogonal) symptom factors included (i.e., the disorganization factor
excluded)] for both the FEP [F(1,18)527.15, p#.001) and SCZ [F(1,32)524.69,
p,.001] groups. In neither case was there a significant time x symptom
interaction: FEP [F(4,72)51.13, p5.35]; SCZ [F(4,128)51.00, p5.41]. The
patient groups also did not differ on their degree of differential symptom change
(across the 5 PANSS factors) over time: time x group x symptom interaction
F(4,200)5.68, p5.61. There was also not a significant difference in degree of
change over time on the Cuesta and Peralta disorganization factor: F(1,50)5.01,
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p5.92. All of this suggests that any group differences in task performance, either
at a given time point, or across time, are not due to patient differences in
symptomatology or treatment response.
Task performance: BSF condition
First, BSF performance was considered. Accuracy was high for all groups at each
time point, considered separately. Time 1: FEP mean5.93 (SD5.08), SCZ5.90
(SD5.10), CON5.97 (SD5.04); Time 2: FEP5.92 (SD5.08), SCZ5.92
(SD5.07), CON5.97 (.03). This suggests that all groups were actively engaged in
the task. However, there were main effects of group at both points: Time 1
F(2,90)56.75, p5.002; Time 2 F(2,90)56.23, p5.003. At Time 1, post-hoc Scheffe´
tests indicated that the SCZ group was less accurate than the CON group
(p5.002), while no other pairwise comparisons were significant (both ps5.27). At
Time 2, the FEP group performed more poorly than the CON group (p5.03), and
the SCZ group performed more poorly than the CON group (p5.007), but the
two patient groups did not differ from each other (p5.98). As noted above,
because of these group differences in BSF performance, the primary data analyses
focused on group-wise differences in the degree of performance decrement from
the BSF condition, in the LSF and HSF conditions (see Figs. 2 and 3).
Performance at Times 1 and 2 in HSF and LSF conditions, relative to BSF
At Time 1, accuracy data indicated that the groups were equivalent in their
decrease in performance (relative to BSF) in both the LSF [F(2,90)50.64, p5.53]
and HSF [F(2,90)50.50, p5.61] conditions. The groups were also similar on the
differential sensitivity [F(2,90)51.27, p5.29] and degradation [F(2,90)50.20,
p5.82]] indices (see Fig. 4). Findings were similar when all subjects present at
Time 1 were included in the analysis (i.e., when there was no BSF cut-off), when
the cutoff for inclusion was 61.11% correct (i.e., above chance) at Time 1 only,
and when it was 90% correct in BSF at Time 1 only (see S1 Results). This suggests
that the accuracy results are not artifacts of attrition by a unique subgroup of
subjects.
Time 1 RT data indicated that the groups did not differ on their degree of RT
increase from BSF to HSF [F(2,90)50.77, p5.46]. However, there was a
significant group difference on degree of RT change from BSF to LSF
[F(2,90)54.80, p5.01]. The FEP group demonstrated the largest relative increase
in RT in the LSF condition, and this was significantly larger than that
demonstrated by the CON group (p5.01). The FEP group did not differ from the
SCZ group (p5.14), and the SCZ and CON groups did not differ on this variable
(p5.49). On the sensitivity RT index, there was a significant effect of group:
F(2,90)53.16, p,.05. The FEP group showed the least differential sensitivity
between the LSF and HSF conditions, although no pairwise comparisons reached
statistical significance: FEP ,SCZ, p,.08; FEP ,CON, p5.09; SCZ5CON,
p..99. The groups did not differ in their overall performance decline when SF
information was removed: degradation RT index F(2,90)51.98, p5.14. Findings
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were similar when all subjects present at Time 1 were included in the analysis (i.e.,
when there was no BSF cut-off), when the cutoff for inclusion was 61.11% correct
at Time 1 only, and when it was 90% correct in BSF at Time 1 only (see S1
Results). This suggests that the RT results are not artifacts of attrition by a unique
subgroup of subjects.
Fig. 2. Performance decrement from BSF, in LSF and HSF conditions, for each group, at Time 1. Error
bars reflect +/2 1 SE.
doi:10.1371/journal.pone.0114642.g002
Fig. 3. Performance decrement from BSF, in LSF and HSF conditions, for each group, at Time 2. Error
bars reflect +/2 1 SE.
doi:10.1371/journal.pone.0114642.g003
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At Time 2, there was again no group difference in HSF condition accuracy
relative to BSF: F(2,90)51.69, p5.19. However, the groups differed in their degree
of performance decline in the LSF condition: F(2,90)55.09, p5.008. Post-hoc
Scheffe´ tests indicated that the largest degree of performance decline was in the
SCZ group (mean5211%(SD510%)). This was significantly different than the
performance of the CON group (26% (5%); p5.01), and approached a
significant reduction compared to the FEP group (27%(5%); p5.07). There was
no group difference on the sensitivity index [F(2,90)50.84, p5.43], but the
groups differed significantly on the degradation index [F(2,90)54.25, p,.02].
Post-hoc Scheffe´ tests indicated that at Time 2, the SCZ group demonstrated more
overall performance impairment when SF information was removed from the
facial images, compared to the FEP (p,.03) group, with a trend towards poorer
performance than the CON (p,.09) group, while the FEP and CON groups did
not differ from each other (p5.79). Findings were similar when the Time 2 data
set was restricted to only those subjects scoring above 90% in the BSF condition at
Time 2, with the notable exception that the SCZ group was no longer significantly
worse in in the LSF condition (see S1 Results). These findings, with the larger data
set, are further evidence that the results from the restricted data set are not
influenced by subject attrition.
Time 2 RT data indicated that the groups did not differ on their degree of RT
increase from BSF to HSF [F(2,90)50.69, p5.50]. The groups were also
equivalent on their degree of RT change from BSF to LSF [F(2,90)51.72, p5.19],
and on the sensitivity [F(2,90)50.62, p5.54], and degradation [F(2,90)50.88,
p5.42] RT indices.
Fig. 4. Overall degradation in performance from BSF (summed across HSF and LSF conditions), by
group and time. Error bars reflect +/2 1 SE.
doi:10.1371/journal.pone.0114642.g004
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Change over time
In the accuracy data, examined across time points, there was a significant main
effect of condition, with accuracy in the HSF condition (relative to BSF) declining
more than that in the LSF condition (relative to BSF): F(1,88)566.73, p,.001. No
other accuracy effects were significant: time F(1,88)50.07, p5.79; group
F(2,88)51.22, p5.30; group x time F(2,88)52.95, p,.06; condition x group
F(2,88)51.43, p5.25; time x condition F(1,88)51.77, p5.19; time x condition x
group F(2,88)50.13, p5.88. Exploration of the trend toward a group x time
interaction revealed non-significant effects of time for the FEP [F(1,21)50.99,
p5.33] and CON [F(1,34)51.67, p5.21] groups, and a trend towards a significant
effect for the SCZ group (with relative performance declines from BSF being
larger at Time 2 than at Time 1): F(1,33)52.95; p,.10. On the differential
sensitivity index, there were no significant effects: time F(1,88)51.77, p5.19;
group F(2,88)51.43, p5.25; time x group interaction: F(2,88)50.13, p5.88. On
the degradation index the effects of time [F(1,88)50.07, p5.79] and group
[F(2,88)51.22, p5.30] were not significant. However, there was a trend towards a
significant time x group interaction: F(2,88)52.95, p,.06. Exploration of this
effect revealed non-significant effects of time for the FEP [t(21)51.00, p5.33] and
CON [t(34)51.29, p5.21] groups, and a trend towards an effect of time for the
SCZ group [t(33)521.72, p,.10].
In the RT data, examined across time points, there was a significant main effect
of condition, with the relative increase in RT in the HSF condition exceeding that
in the LSF condition: F(1,88)514.78, p,.001. No other RT effects were
significant: time F(1,88)50.04, p5.84; group F(2,88)52.06, p5.13; time x group
F(2,88)50.12, p5.89; condition x group F(2,88)51.25, p5.29; time x condition
F(1,88)50.73, p5.40; time x condition x group F(2,88)50.65, p5.53. There were
also no significant RT effects on the sensitivity index: time [F(1,88)50.73, p5.40;
group F(2,88)51.25, p5.29; time x group F(2,88)50.65, p5.53], or the
degradation index [time F(1,88)50.04, p5.84; group F(2,88)52.06, p5.13; time x
group F(2,88)50.12, p5.89].
Visual acuity and performance
Because poorer visual acuity, by definition, reduces the resolution of fine detail
(e.g., HSF information), we evaluated the relationship between visual acuity and
task performance. Data presented here are for binocular acuity, but the results are
similar for left or right eye acuity only (see Table 1 for values). There were
significant correlations between visual acuity and all accuracy indices involving
the HSF condition, and in all cases, poorer acuity was associated with a greater
performance decline in the HSF relative to the BSF or LSF condition: BSF-HSF
decline at Time 1 rs52.36, p,.001; BSF-HSF decline at Time 2 rs52.43, p,.001;
sensitivity at Time 1 rs52.29, p5.008; sensitivity at Time 2 rs52.35, p5.001;
degradation at Time 1 rs52.28, p5.01; degradation at Time 2 rs52.36, p5.001.
There were no relationships between visual acuity and performance in the LSF
condition alone at Time 1 (rs5.00, p..99] or Time 2 (rs52.02, p5.89].
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The relationships reported above were weaker for the RT data, where the only
significant result was with LSF-related accuracy decline at Time 1, and this result
was modest and would not survive correction for multiple correlations: BSF-HSF
decline at Time 1 rs52.07, p5.51; BSF-HSF decline at Time 2 rs52.05, p5.067;
sensitivity at Time 1 rs5.19, p5.09; sensitivity at Time 2 rs5.04, p5.72;
degradation at Time 1 rs5.02, p5.86; degradation at Time 2 rs52.08, p5.50;
BSF-LSF decline at Time 1 rs5.27, p5.01; BSF-LSF decline at Time 2 rs5.02,
p5.85]. The RT findings also indicate no evidence of speed-accuracy trade-off.
Because the groups did not differ in overall visual acuity, while acuity was
related to performance within the sample as a whole, analyses of covariance –
controlling for visual acuity - on the between-group tests were appropriate [70].
In all cases except one, the results were qualitatively the same. The sole exception
was for the group difference on the degradation index at Time 2, which was no
longer significant: F(2, 83)52.12, p5.13.
Symptom change and correlates of performance
Few of the correlations between task performance and symptoms were significant,
for the patient group as a whole or for each group separately. Moreover, no clear
pattern emerged, and none of the significant values would survive correction for
multiple tests. These analyses are reported in S1 Results.
Medication and performance
Data on changes in medication dosages over time, for both antipsychotic
medications and benzodiazepines, are presented in S1 Results. Data on
correlations between medication dosages (CPZ and diazepam equivalent) and
sensitivity and degradation (accuracy) index scores at Time 1 and Time 2, as well
as correlations between change in medication dosages over time and changes on
these task indices, are also presented in S1 Results. Out of all correlations
performed (for both patient groups separately and for both patient groups
combined), only one value was significant, and this would not survive correction
for multiple comparisons. We conclude therefore that task performance was
unrelated to medication dosage.
Discussion
The primary question addressed by this study was whether high and low SF
processing abilities, as reflected in face processing, change as schizophrenia
patients move from the acute to the stabilization phase of illness. We did not find
evidence of significant improvement over time in the SCZ group, although there
was a trend indicating that these patients were more sensitive to changes in spatial
frequency composition of facial stimuli as they began recovering from acute
illness. Subject attrition cannot account for the Time 1 results (i.e., the results of
our analyses restricting the data set to only subjects who were present at both time
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points). This is because the same results were obtained with larger and smaller
versions of the data set, which both included and excluded subjects present at
Time 2 in the Time 1 analyses, and used 2 different performance criteria cutoffs
(61.11% and 90% in the BSF condition). Moreover, a direct comparison of
subjects who were present versus not present at Time 2 revealed no differences on
performance variables at Time 1. However, the possibility that some of our results
at Time 2 could be due to loss of subjects who were only present at Time 1 cannot
be completely ruled out. It is possible, for example, that the trend towards a
relative worsening over time for the SCZ group is, in part, an artifact of attrition.
As noted above, however, there was no evidence that subjects who left the study
after the admission testing performed differently on any variable than did subjects
who were tested at both time points. It is also possible that the appearance of
greater impairment for the SCZ group at Time 2 is a statistical artifact.
Specifically, on the 2 variables where the SCZ group performed most abnormally
(LSF accuracy decline from BSF, and overall performance degradation after
removal of SFs), the SCZ group demonstrated small increases in SD from Time 1
to 2, whereas the FEP group demonstrated ,40% reductions in SD across time
points, and the CON group stayed the same (LSF) or declined slightly
(degradation). We also consider it unlikely that the observed pattern of results was
due to the SCZ group having the shortest time between testing sessions of all the
groups. This is because the two patient groups did not differ on symptoms at
either time point, or on degree of symptom change across time points, and
because the slight worsening of SCZ group performance over time occurred in the
context of significant clinical improvement.
A complicating factor in interpreting this study’s data is that the SCZ group did
not demonstrate specific SF processing impairments, independent of a generalized
performance deficit (as revealed in the BSF condition). The only possible
exception to this was reduced LSF processing at the discharge assessment, but this
effect disappeared when subjects who made a significant number of errors in the
BSF condition (where few errors are expected) were removed, suggesting again
that some of the initial effect was due to generalized performance impairments
(including more variable task engagement). It is also possible that the change in
statistical significance level across those 2 analyses was an artifact of lower power
after reducing the sample size. Overall, however, the normal SF processing in this
study is consistent with the findings of McBain et al.[20] that SF detection is
normal, but that this information may get distorted at higher levels of processing
(e.g., emotion identification) which were not relevant to the task we used.
How can these results be understood within the context of other prior studies?
One possibility is that, as noted by Laprevote and colleagues [17, 18],
schizophrenia patients have a bias towards processing LSF stimuli in faces and
objects, and, to the extent that this is a feature of the stabilization-stable phases of
illness, then as patients move into these phases, face processing would be most
disrupted by removal of LSF information. However, this is clearly a post-hoc and
speculative hypothesis. What we can say with more certainty is that there is not a
generalized LSF processing impairment in schizophrenia, and that more research
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is needed to clarify under what conditions different spatial frequencies are
processed normally or abnormally. Also, independent of spatial frequency type,
there was a greater degree of performance decline due to any loss of information
for the SCZ group, compared to the other groups, at Time 2, and a trend for this
effect to be more pronounced at Time 2 than Time 1. The overall effect is
consistent with past findings that image degradation has a stronger effect on
schizophrenia patients than other groups [71–73], while the possible change over
time requires further investigation.
An important finding from this study was that task performance was
significantly determined by visual acuity. In particular, poorer visual acuity
reduced accuracy on all indices reflecting HSF processing, at both time points, and
all of these results survive correction for multiple comparisons. In contrast, there
were no relationships between acuity and LSF processing. This is an internally
consistent pattern of results since, by definition, HSFs involve finer perceptual
distinctions than LSFs. While the groups did not differ in terms of acuity –
because we provided corrective lenses to essentially match subjects on optimal
acuity – the implications of these findings are that studies that do not match
groups on acuity may: 1) confound poor HSF processing with poor acuity; and 2)
reveal group differences in HSF processing, or other aspects of perception
requiring high resolution, that are artifacts of group differences in acuity.
Preliminary evidence consistent with this from this study was that the SCZ-related
performance impairment with SF degradation at Time 2 was no longer significant
when controlling for visual acuity. While this issue has not received much
attention in the cognitive neuroscience of schizophrenia literature, and thus the
extent to which many past findings are artifactual is largely unknown, we believe it
is critical to attend to, because: 1) impairments in acuity have been noted in
children at high risk for schizophrenia [6, 7]; 2) SCZ patients have poorer visual
acuity than the general population [28, 29]; 3) SCZ patients as a group are
characterized by retinal abnormalities (e.g., retinal ganglion cell axon loss) that
can affect acuity [74, 75]; 4) some antipsychotic medications [76], and other
medications taken by SCZ patients [76, 77], can blur vision, leading to increased
difficulty with HSF [78] processing but leaving LSF processing relatively intact (or
enhanced [78]), and, importantly, 5) even small differences in acuity – within the
normal range – can affect performance on visual processing tasks on which SCZ
patients have performed abnormally in past studies, especially when the elements
are composed of higher SFs [79].
A second goal of this study was to compare first-episode and later-episode
patients. The performance of both groups was roughly equivalent on SF indices,
with the only evidence for a difference being at the discharge time point, where
there was a trend for the SCZ group to be more impaired in the BSF-LSF contrast
compared to the FEP group. However, on the degradation index, the SCZ group
demonstrated significantly more impairment than the FEP group at Time 2. This
suggests that the general issue of recognizing degraded images may be something
that progresses over time with an increased number of psychotic episodes.
However, this hypothesis should be considered cautiously given that the effect was
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not found at Time 1, it did not remain after controlling for visual acuity, and that
some abnormalities in the RT data were observed among FEP subjects (but not
hyper-processing of LSF information, as has been found in some studies using
traditional grating stimuli [35, 36]). Nevertheless, we believe the progression
hypothesis is worth pursuing, since there is other evidence that some perceptual
impairments worsen with illness progression [12, 54], as well as cross-sectional
evidence from prior studies that LSF processing may shift from hyper- to hypo-
active after the first episode in schizophrenia [23, 35, 36, 38, 39].
In a prior study using the same task [24], which also found trend level evidence
of poorer LSF processing in schizophrenia, there were significant group
differences in fMRI data, indicating excessive fusiform gyrus activity in this group,
presumably secondary to poorer quality representations emerging from visual
cortex. Therefore, it is also possible that while group differences (e.g., in LSF
processing) do exist, the face processing task we used is simply not sensitive
enough to detect this in the behavioral data (e.g., lower spatial frequencies may be
needed, or there may not be a sufficient number of trials). On the other hand,
there was clearly an effect of the SF manipulation in the behavioral data for all
groups, and so it is not clear how this could not lead to a differential deficit
among SCZ patients if one existed.
Two limitations of the study are noteworthy. First, since we did not include a
separate age-matched control group for FEP subjects, it is not clear whether the
performance of the FEP group is abnormal compared to age-matched healthy
subjects. This is important because low spatial frequency processing can decline
with age [80, 81] (although these effects should be minimal within the age range
used in this study). Second, the low spatial frequency condition in this study used
a level of cycles/degree (2.17) that has been considered medium spatial frequency
in some studies [78], although it is half as low as that of medium frequency
stimuli used in other studies [14], and close to the LSF value (e.g., 1.5 cycles/
degree) used in other studies [66]. Nevertheless, given the general lack of between-
group differences in our LSF condition, additional studies using measures
involving spatial frequency degraded faces should include lower spatial
frequencies.
In conclusion, given the caveats noted above, this study did not find evidence of
a specific SF processing impairment in schizophrenia during a face processing task
in which SFs were independent of the perceptual discrimination that had to be
made (gender discrimination). Moreover, level of SF processing did not change
during recovery from an acute phase of illness. There were also no clear
differences between first-episode psychosis and later-episode schizophrenia
patients in SF processing, although later-episode patients were more affected by
overall stimulus degradation at one of the two time points. These data, in the
context of prior studies of SF processing in schizophrenia, imply that the
conditions under which SF information is processed abnormally are a subset of all
possible conditions, and that it remains largely unclear under what circumstances
(patient, stimuli, mental state, environmental context, etc.) SF information is
processed abnormally relative to psychiatrically healthy subjects. The one clear
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exception to this statement is that our data are consistent with past findings
indicating a lower probability of observing problems in LSF processing when LSF
stimuli are presented at suprathreshold levels, as was in the case in this study. On
the other hand, the evidence for performance decline with image degradation is
consistent with prior studies of degraded stimulus processing in schizophrenia
[71, 72]. This suggests that factors other than specific spatial frequencies are
involved in the problems that patients have in constructing visual representations
of complex stimuli such as faces. We suggest that these factors include poor visual
acuity (secondary to schizophrenia and/or medication), as well as intermediate
level problems involving structural encoding [82], such as perceptual organization
impairments [2, 83, 84].
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